GSK - Avandia: ACCORD - Nissen’s first thoughts
Submitted by PharmaGossip Blog
It’s very hard to sort out,” says Steven Nissen, lead investigator of the trial that linked Avandia to an increased risk of heart attacks.
“We’ve got to be careful not to jump to conclusions.”
“It’s really going to shake things up,” Nissen added. “Clinicians have been taught that getting to lower blood sugar is better.”
Visit 1800blogger to see all of our industry leading blogs.
[?]
We don't know every stock and we want to know your thoughts. Register on Biotech Stocks Blog now and get published within minutes. Before posting, it is recommended that you review our posting guidelines.
